Background/Aim: Home hemodialysis (HHD) has been associated with improved clinical outcomes vs. in-center HD (ICHD). The prevalence of HHD in the United States is still very low at 1.8%. This critical review compares HHD and ICHD outcomes for survival, hospitalization, cardiovascular (CV), nutrition, and quality of life (QoL). Methods: Of 545 publications identified, 44 were not selected after applying exclusion criteria. A systematic review of the identified publications was conducted to compare HHD to ICHD outcomes for survival, hospitalization, CV outcomes, nutrition, and QoL. Results: Regarding mortality, 10 of 13 trials reported 13–52% reduction; three trials found no differences. According to 6 studies, blood pressure and left ventricular size measurements were generally lower in HHD patients compared to similar measurements in ICHD patients. Regarding nutritional status, conflicting results were reported (8 studies); some found improved muscle mass, total protein, and body mass index in HHD vs. ICHD patients, while others found no significant differences. There were no significant differences in the rate of hospitalization between HHD and ICHD in the 6 articles reviewed. Seven studies on QoL demonstrated positive trends in HHD vs. ICHD populations. Conclusions: Despite limitations in the current data, 66% of the publications reviewed (29/44) demonstrated improved clinical outcomes in patients who chose HHD. These include improved survival, CV, nutritional, and QoL parameters. Even though HHD may not be preferred in all patients, a review of the literature suggests that HHD should be provided as a modality choice for substantially more than the current 1.8% of HHD patients in the United States.

Keywords:
Home hemodialysis, Outcomes, Mortality, Quality of life, Cardiovascular blood pressure
1.
Downs SH, Black N: The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health 1998; 52: 377–384.
2.
Rocco MV, Lockridge RS Jr, Beck GJ, Eggers PW, Gassman JJ, Greene T, et al: The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int 2011; 80: 1080–1091.
3.
Nesrallah GE, Lindsay RM, Cuerden MS, Garg AX, Port F, Austin PC, et al: Intensive hemodialysis associates with improved survival compared with conventional hemodialysis. J Am Soc Nephrol 2012; 23: 696–705.
4.
Marshall MR, Hawley CM, Kerr PG, Polkinghorne KR, Marshall RJ, Agar JW, et al: Home hemodialysis and mortality risk in Australian and New Zealand populations. Am J Kidney Dis 2011; 58: 782–793.
5.
Johansen KL, Zhang R, Huang Y, Chen SC, Blagg CR, Goldfarb-Rumyantzev AS, et al: Survival and hospitalization among patients using nocturnal and short daily compared to conventional hemodialysis: a USRDS study. Kidney Int 2009; 76: 984–990.
6.
Kjellstrand CM, Buoncristiani U, Ting G, Traeger J, Piccoli GB, Sibai-Galland R, et al: Short daily haemodialysis: survival in 415 patients treated for 1006 patient-years. Nephrol Dial Transplant 2008; 23: 3283–3289.
7.
Blagg CR, Kjellstrand CM, Ting GO, Young BA: Comparison of survival between short-daily hemodialysis and conventional hemodialysis using the standardized mortality ratio. Hemodial Int 2006; 10: 371–374.
8.
Nitsch D, Steenkamp R, Tomson CR, Roderick P, Ansell D, MacGregor MS: Outcomes in patients on home haemodialysis in England and Wales, 1997–2005: a comparative cohort analysis. Nephrol Dial Transplant 2010; 26: 1670–1677.
9.
Lockridge RS, Kjellstrand CM: Nightly home hemodialysis: outcome and factors associated with survival. Hemodial Int 2011; 15: 211–218.
10.
Woods JD, Port FK, Stannard D, Blagg CR, Held PJ: Comparison of mortality with home hemodialysis and center hemodialysis: a national study. Kidney Int 1996; 49: 1464–1470.
11.
Saner E, Nitsch D, Descoeudres C, Frey FJ, Uehlinger DE: Outcome of home haemodialysis patients: a case-cohort study. Nephrol Dial Transplant 2005; 20: 604–610.
12.
MacRae JM, Rose CL, Jaber BL, Gill JS: Utilization and outcome of ‘out-of-center hemodialysis’ in the United States: a contemporary analysis. Nephron Clin Pract 2010; 116:c53–c59.
13.
Rocco MV, Daugirdas JT, Greene T, Lockridge RS, Chan C, Pierratos A, et al: Long-term effects of frequent nocturnal hemodialysis on mortality: the Frequent Hemodialysis Network (FHN) nocturnal trial. Am J Kidney Dis 2015; 66: 459–468.
14.
Rydell H, Clyne N, Segelmark M: Home- or Institutional Hemodialysis? – a matched pair-cohort study comparing survival and some modifiable factors related to survival. Kidney Blood Press Res 2016; 41: 392–401.
15.
Weinhandl ED, Liu J, Gilbertson DT, Arneson TJ, Collins AJ: Survival in daily home hemodialysis and matched thrice-weekly in-center hemodialysis patients. J Am Soc Nephrol 2012; 23: 895–904.
16.
Wolfe RA, Gaylin DS, Port FK, Held PJ, Wood CL: Using USRDS generated mortality tables to compare local ESRD mortality rates to national rates. Kidney Int 1992; 42: 991–996.
17.
Kotanko P, Garg AX, Depner T, Pierratos A, Chan CT, Levin NW, et al: Effects of frequent hemodialysis on blood pressure: results from the randomized Frequent Hemodialysis Network trials. Hemodial Int 2015; 19: 386–401.
18.
Culleton BF, Walsh M, Klarenbach SW, Mortis G, Scott-Douglas N, Quinn RR, et al: Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. JAMA 2007; 298: 1291–1299.
19.
McGregor DO, Buttimore AL, Lynn KL, Nicholls MG, Jardine DL: A comparative study of blood pressure control with short in-center versus long home hemodialysis. Blood Purif 2001; 19: 293–300.
20.
Chan CT, Greene T, Chertow GM, Kliger AS, Stokes JB, Beck GJ, et al: Determinants of left ventricular mass in patients on hemodialysis: Frequent Hemodialysis Network (FHN) trials. Circ Cardiovasc Imaging 2012; 5: 251–261.
21.
Kraus M, Burkart J, Hegeman R, Solomon R, Coplon N, Moran J: A comparison of center-based vs. home-based daily hemodialysis for patients with end-stage renal disease. Hemodial Int 2007; 11: 468–477.
22.
Palmer SC, Palmer AR, Craig JC, Johnson DW, Stroumza P, Frantzen L, Leal M, Hoischen S, Hegbrant J, Strippoli GF: Home versus in-centre haemodialysis for end-stage kidney disease. – PubMed – NCBI [Internet]. 2014. http://www.ncbi.nlm.nih.gov/pubmed/?term=Palmer+Cochrane+home+hemodialysis (cited January 6, 2016).
23.
Susantitaphong P, Koulouridis I, Balk EM, Madias NE, Jaber BL: Effect of frequent or extended hemodialysis on cardiovascular parameters: a meta-analysis. Am J Kidney Dis 2012; 59: 689–699.
24.
Ageborg M, Allenius BL, Cederfjäll C: Quality of life, self-care ability, and sense of coherence in hemodialysis patients: a comparative study. Hemodial Int 2005; 9(suppl 1):S8–S14.
25.
Heidenheim AP, Muirhead N, Moist L, Lindsay RM: Patient quality of life on quotidian hemodialysis. Am J Kidney Dis 2003; 42(1 suppl):36–41.
26.
McFarlane PA, Bayoumi AM, Pierratos A, Redelmeier DA: The quality of life and cost utility of home nocturnal and conventional in-center hemodialysis. Kidney Int 2003; 64: 1004–1011.
27.
Mohr PE, Neumann PJ, Franco SJ, Marainen J, Lockridge R, Ting G: The case for daily dialysis: its impact on costs and quality of life. Am J Kidney Dis 2001; 37: 777–789.
28.
Watanabe Y, Ohno Y, Inoue T, Takane H, Okada H, Suzuki H: Home hemodialysis and conventional in-center hemodialysis in Japan: a comparison of health-related quality of life. Hemodial Int 2014; 18(suppl 1):S32–S38.
29.
Kooistra MP, Vos J, Koomans HA, Vos PF: Daily home haemodialysis in The Netherlands: effects on metabolic control, haemodynamics, and quality of life. Nephrol Dial Transplant 1998; 13: 2853–2860.
30.
Mowatt G, Vale L, MacLeod A: Systematic review of the effectiveness of home versus hospital or satellite unit hemodialysis for people with end-stage renal failure. Int J Technol Assess Health Care 2004; 20: 258–268.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.